Tampere Coronary Artery Disease and Sudden Cardiac Arrest Study

The goal of this observational study is to recognize clinical and genetic risk factors for sudden cardiac arrest (SCA) and death (SCD) in patients with coronary artery disease (CAD). The main questions it aims to answer are: Are we able to recognize clinical or treatment-related risk factors for SCA or SCD? Can we identify new genetic risk factors for SCA or SCD in patients under 75 years? Participants diagnosed with CAD answer a short survey about their medical history and socioeconomic status. A standard ECG addition to a five (5) minute ECG recording is taken from all the study subjects. In addition to a few short physiological tests (e.g. blood pressure, height, weight, grip strength), a blood sample is withdrawn from a selected group of study subjects. Medical healthcare records are used to follow all study subjects, and no follow-up visits are required.

NCT Number	NCT06804499
Lead Sponsor	Tampere Heart Hospital Collaborators: Tampere University, Tampere University Hospital
Conditions	Sudden Cardiac Arrest, Sudden Cardiac Death, Sudden Cardiac Death Due to Cardiac Arrhythmia, Coronary Arterial Disease (CAD), Acute Coronary Event
Enrollment	4,000 participants
Start Date	2025-01-13
Primary Completion	2027-12-31 (estimated)
Study Completion	2042-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-02-03